New drug tested to fight common hair loss
Disease control
Completed
This study tested an experimental topical treatment called PP405 for common pattern hair loss (androgenetic alopecia). It involved 78 adults to check the treatment's safety, how much of the drug gets into the body, and its early effects. The trial had two parts: a 28-day blinded …
Phase: PHASE2 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC